ICD-10-CM Billable Code

E31.1

Polyglandular hyperfunction

Clinical Classification Guidelines

Excludes Type 1

  • multiple endocrine adenomatosis (E31.2-)
  • multiple endocrine neoplasia (E31.2-)

Medical Intelligence & Overview

Polyglandular hyperfunction, classified under ICD-10 code E31.1, is a medical condition characterized by the overactivity of multiple endocrine glands. Endocrine glands produce hormones that regulate vital functions such as metabolism, growth, and development. When these glands become hyperactive simultaneously, it results in an excessive production of hormones, leading to various health issues. The condition can affect different glands like the thyroid, adrenal, and parathyroid glands, among others. Recognizing and understanding this disorder is essential for managing its effects and improving patient outcomes.

Causes & Symptoms

Clinical Causes: Autoimmune Disorders: The most common cause involves autoimmune reactions where the body's immune system mistakenly attacks its endocrine glands, leading to hyperactivity. Genetic Factors: Certain inherited genes can predispose individuals to develop multiple gland hyperactivity conditions. Genetic Syndromes: Specific syndromes, such as Multiple Endocrine Neoplasia (MEN), can cause tumors or overgrowth in multiple endocrine tissues, resulting in hyperfunction. Tumors: Benign or malignant tumors in endocrine glands may produce excess hormones, leading to hyperactivity. Environmental Factors: Less commonly, environmental exposure or stress may contribute to hormonal overproduction, especially in predisposed individuals. Infections: Certain infections can temporarily or permanently affect endocrine gland function, sometimes leading to hyperfunction. Other Medical Conditions: Rarely, underlying chronic illnesses or systemic diseases may contribute to generalized gland hyperactivity.

Key Symptoms: Weight fluctuations, often with unexplained weight gain or loss Increased heart rate (tachycardia) Elevated blood pressure (hypertension) Excessive sweating (hyperhidrosis) Nervousness, anxiety, or irritability Muscle weakness or fatigue Heat intolerance or increased body temperature Changes in appetite or digestive issues Altered sleep patterns Enlarged glands or goiter Irregular or rapid menstrual cycles Skin thinning or changes in skin texture In some cases, visual disturbances or eye symptoms

Diagnostic & Treatment

Diagnosis Path: Diagnosing polyglandular hyperfunction involves several steps to identify overactivity across multiple glands. Key approaches include: - **Clinical Evaluation:** A comprehensive medical history and physical examination to identify symptoms and signs of hormone excess. - **Laboratory Tests:** Blood and urine tests measuring hormone levels, including thyroid hormones, cortisol, parathyroid hormone, and others relevant to suspected glands. - **Imaging Studies:** Techniques such as ultrasound, MRI, or CT scans to visualize gland size, structure, and the presence of tumors or abnormal growths. - **Autoimmune Panels:** Tests to detect specific antibodies that may indicate autoimmune gland involvement. - **Genetic Testing:** In cases linked to hereditary syndromes like MEN, genetic analysis may be necessary. Accurate diagnosis often requires a combination of these assessments to understand the extent and specific glands involved.

Treatment Protocols: Managing polyglandular hyperfunction typically involves a multidisciplinary approach tailored to the affected glands and severity of symptoms: - **Medication:** Use of drugs to control hormone levels, such as antithyroid medications, corticosteroids, or other hormone modulators. - **Surgery:** Removal of tumors or overactive glands may be necessary in cases where medication does not control hormone production or if tumors are present. - **Monitoring and Follow-up:** Regular blood tests and imaging to track hormone levels and gland health. - **Management of Symptoms:** Supportive therapies to address specific symptoms, including lifestyle modifications and supportive medications. - **Addressing Underlying Causes:** Treating autoimmune components or genetic conditions as part of the broader management plan. It's important to recognize that treatment plans vary significantly based on individual factors and specific gland involvement, emphasizing the importance of specialist care.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is E31.1 a billable ICD-10 code?
Yes, E31.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report E31.1?
Clinical documentation must specify the nature of Polyglandular hyperfunction and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Related Diagnosis Codes

Clinical Meta Tags

polyglandular hyperfunction